Evaluation of Fluconazole treatment effects on acute biliary pancreatitis
Not Applicable
- Conditions
- biliary acute pancreatitisbiliary acute pancreatitis.
- Registration Number
- IRCT2013082714333N3
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
patients consists of those who have been diagnosed with acute biliary pancreatitis based on clinical; laboratory and ultrasound results.criteria excluded: Pregnant women; patients with a history of previous hypersensitivity to fluconazole to mention; person that any allergies or suffer from the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of disease. Timepoint: at starting point and six months later. Method of measurement: Based on Ratson criteria and CT. Scan.;Necessity to operation. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Duration of staying in hospita. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Duration of staying in hospital. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Costs of disease. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Treatments. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Complications. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.;Mortality rate. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records.
- Secondary Outcome Measures
Name Time Method